These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33088636)

  • 61. Characterization of immune checkpoint inhibitor-associated fulminant type 1 diabetes associated with autoantibody status and ethnic origin.
    Qiu J; Luo S; Yin W; Guo K; Xiang Y; Li X; Liu Z; Zhou Z
    Front Immunol; 2022; 13():968798. PubMed ID: 36451831
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An immunohistochemical study of macrophage influx and the co-localization of inducible nitric oxide synthase in the pancreas of non-obese diabetic (NOD) mice during disease acceleration with cyclophosphamide.
    Reddy S; Yip S; Karanam M; Poole CA; Ross JM
    Histochem J; 1999 May; 31(5):303-14. PubMed ID: 10461865
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical and HLA genotype analysis of immune checkpoint inhibitor-associated diabetes mellitus: a single-center case series from China.
    Liu YC; Liu H; Zhao SL; Chen K; Jin P
    Front Immunol; 2023; 14():1164120. PubMed ID: 37359544
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes.
    Imagawa A; Hanafusa T; Makino H; Miyagawa JI; Juto P
    Diabetologia; 2005 Feb; 48(2):290-3. PubMed ID: 15654603
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical and immunological characteristics of PD-1 associated fulminant type 1 diabetes mellitus.
    Qiu J; Luo S; Yin W; Li X; Zhou Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 48(1):49-58. PubMed ID: 36935177
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.
    Godwin JL; Jaggi S; Sirisena I; Sharda P; Rao AD; Mehra R; Veloski C
    J Immunother Cancer; 2017; 5():40. PubMed ID: 28515940
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rapid improvement of severe fatty liver in a case of fulminant type 1 diabetes following insulin treatment.
    Noda S; Harai N; Komai S; Inukai T; Watanabe T; Hosokawa T; Antoku A; Muroi Y; Hayashida R; Okuma H; Suzuki Y; Tsuchiya K
    Diabetol Int; 2024 Apr; 15(2):297-301. PubMed ID: 38524939
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats.
    Medina A; Parween S; Ullsten S; Vishnu N; Siu YT; Quach M; Bennet H; Balhuizen A; Åkesson L; Wierup N; Carlsson PO; Ahlgren U; Lernmark Å; Fex M
    Diabetologia; 2018 Apr; 61(4):896-905. PubMed ID: 29209740
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence.
    Imagawa A; Hanafusa T; Miyagawa J; Matsuzawa Y
    Ann Med; 2000 Nov; 32(8):539-43. PubMed ID: 11127931
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fulminant Type 1 Diabetes Mellitus Developed about Half a Year after Discontinuation of Immune Checkpoint Inhibitor Combination Therapy with Nivolumab and Ipilimumab: A Case Report.
    Yaura K; Sakurai K; Niitsuma S; Sato R; Takahashi K; Arihara Z
    Tohoku J Exp Med; 2021 Aug; 254(4):253-256. PubMed ID: 34373422
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Glycated Albumin (GA) to HbA1c Ratio Reflects Shorter-Term Glycemic Control than GA: Analysis of Patients with Fulminant Type 1 Diabetes.
    Koga M; Inada S; Nakao T; Kawamori R; Kasayama S
    J Clin Lab Anal; 2017 Jan; 31(1):. PubMed ID: 27386821
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes.
    Tanaka S; Nishida Y; Aida K; Maruyama T; Shimada A; Suzuki M; Shimura H; Takizawa S; Takahashi M; Akiyama D; Arai-Yamashita S; Furuya F; Kawaguchi A; Kaneshige M; Katoh R; Endo T; Kobayashi T
    Diabetes; 2009 Oct; 58(10):2285-91. PubMed ID: 19641142
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rare, late onset of immune checkpoint inhibitor-induced type 1 diabetes mellitus in a patient with small-cell lung cancer treated with serplulimab: a case report and review of the literature.
    Ning P; Liu S; Cao H
    J Med Case Rep; 2024 Jan; 18(1):51. PubMed ID: 38247005
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glycemic control indicator levels at diagnosis of neonatal diabetes mellitus: Comparison with other types of insulin-dependent diabetes mellitus.
    Suzuki S; Furuya A; Tanahashi Y; Azuma H; Bando Y; Kasayama S; Koga M
    Pediatr Diabetes; 2017 Dec; 18(8):767-771. PubMed ID: 27995726
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A case of fulminant type 1 diabetes with transiently positive anti-GAD antibodies.
    Iwaoka T
    Endocr J; 2003 Apr; 50(2):225-31. PubMed ID: 12803244
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes.
    Krogvold L; Wiberg A; Edwin B; Buanes T; Jahnsen FL; Hanssen KF; Larsson E; Korsgren O; Skog O; Dahl-Jørgensen K
    Diabetologia; 2016 Mar; 59(3):492-501. PubMed ID: 26602422
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Durvalumab-induced diabetic ketoacidosis followed by hypothyroidism.
    Patel S; Chin V; Greenfield JR
    Endocrinol Diabetes Metab Case Rep; 2019 Dec; 2019():. PubMed ID: 31829972
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Type 1 diabetes related to immune checkpoint inhibitors.
    Tachibana M; Imagawa A
    Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101657. PubMed ID: 35450793
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fulminant type 1 diabetes mellitus: a new class of type 1 diabetes.
    Shibasaki S; Imagawa A; Hanafusa T
    Adv Exp Med Biol; 2012; 771():20-3. PubMed ID: 23393667
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Detecting insulitis in type 1 diabetes with ultrasound phase-change contrast agents.
    Ramirez DG; Ciccaglione M; Upadhyay AK; Pham VT; Borden MA; Benninger RKP
    Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34607942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.